IL95820A - Preparations for the treatment of inflammatory or allergic painful physical defects containing SIC-8-methyl-N- and anilyl-6-nonanamide - Google Patents
Preparations for the treatment of inflammatory or allergic painful physical defects containing SIC-8-methyl-N- and anilyl-6-nonanamideInfo
- Publication number
- IL95820A IL95820A IL9582090A IL9582090A IL95820A IL 95820 A IL95820 A IL 95820A IL 9582090 A IL9582090 A IL 9582090A IL 9582090 A IL9582090 A IL 9582090A IL 95820 A IL95820 A IL 95820A
- Authority
- IL
- Israel
- Prior art keywords
- composition
- nonenamide
- cis
- vanillyl
- methyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 230000001354 painful effect Effects 0.000 title claims abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 9
- 230000000172 allergic effect Effects 0.000 title claims abstract description 7
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 7
- 230000002757 inflammatory effect Effects 0.000 title claims abstract description 6
- 239000006071 cream Substances 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 14
- 239000007924 injection Substances 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 210000004400 mucous membrane Anatomy 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 4
- 239000006193 liquid solution Substances 0.000 claims description 3
- 239000006194 liquid suspension Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 9
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 66
- 229960002504 capsaicin Drugs 0.000 description 32
- 235000017663 capsaicin Nutrition 0.000 description 32
- 208000002193 Pain Diseases 0.000 description 15
- 239000003981 vehicle Substances 0.000 description 11
- 108090000189 Neuropeptides Proteins 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 4
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 102000003797 Neuropeptides Human genes 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000779 depleting effect Effects 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- 206010024769 Local reaction Diseases 0.000 description 2
- 241000722363 Piper Species 0.000 description 2
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000007913 intrathecal administration Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 238000013222 sprague-dawley male rat Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000452734 Eudoraea Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 210000004960 anterior grey column Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036403 neuro physiology Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/452,476 US5063060A (en) | 1989-12-19 | 1989-12-19 | Compositions and method for treating painful, inflammatory or allergic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL95820A true IL95820A (en) | 1996-08-04 |
Family
ID=23796595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9582090A IL95820A (en) | 1989-12-19 | 1990-09-27 | Preparations for the treatment of inflammatory or allergic painful physical defects containing SIC-8-methyl-N- and anilyl-6-nonanamide |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5063060A (de) |
| EP (1) | EP0506658B1 (de) |
| JP (1) | JPH0780761B2 (de) |
| KR (1) | KR950015056B1 (de) |
| AT (1) | ATE138567T1 (de) |
| AU (1) | AU645023B2 (de) |
| CA (1) | CA2070685C (de) |
| DE (1) | DE69027220T2 (de) |
| DK (1) | DK0506658T3 (de) |
| ES (1) | ES2087160T3 (de) |
| IL (1) | IL95820A (de) |
| RU (1) | RU2095060C1 (de) |
| WO (1) | WO1991008738A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU670094B2 (en) * | 1992-04-23 | 1996-07-04 | Berlex Laboratories, Inc. | Bioadhesive solid mineral oil emulsion |
| US6063381A (en) * | 1993-05-19 | 2000-05-16 | Staggs; Jeff J. | Therapeutic uses of pungent botanicals and their related compounds |
| US6635659B1 (en) * | 1995-03-20 | 2003-10-21 | Arrie Kegler | Topical formulation for arthritic symptoms treatment |
| US6248788B1 (en) | 1996-11-06 | 2001-06-19 | The Regents Of The University Of California | Therapeutic method with capsaicin and capasicin analogs |
| US6239180B1 (en) | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| US5840762A (en) * | 1996-01-12 | 1998-11-24 | Genderm Corporation | Method for the treatment of cardiac arrhythmias and shortening of action potential duration |
| DE19622271A1 (de) * | 1996-06-03 | 1997-12-04 | Basf Ag | Chirale Verbindungen |
| GB9711962D0 (en) | 1997-06-10 | 1997-08-06 | Reckitt & Colmann Prod Ltd | Therapeutically active compositions |
| JP4677063B2 (ja) * | 1997-07-18 | 2011-04-27 | 帝國製薬株式会社 | オランダカラシエキス配合外用製剤 |
| US6284797B1 (en) * | 1999-04-12 | 2001-09-04 | Donald A. Rhodes | Topical treatment of pain and to promote healing |
| CN102205127A (zh) * | 2002-12-18 | 2011-10-05 | 阿尔乔医疗公司 | 类辣椒素的给药 |
| US20040191338A1 (en) * | 2002-12-18 | 2004-09-30 | Algorx | Administration of capsaicinoids |
| US20040146464A1 (en) * | 2003-01-23 | 2004-07-29 | Bernstein Joel E. | Compositions and method for daily tooth and gum care |
| US20050085552A1 (en) * | 2003-10-16 | 2005-04-21 | Winston Laboratories, Inc. | Method for providing long-lasting pain relief through intrathecal administration of civamide |
| US7244446B2 (en) * | 2003-10-16 | 2007-07-17 | Winston Laboratories, Inc. | Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
| MXPA06014592A (es) * | 2004-06-15 | 2007-05-23 | Ajinomoto Kk | Pimiento seco que contiene capsinoide y metodo de secado para el mismo. |
| RU2268256C1 (ru) * | 2004-07-07 | 2006-01-20 | Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) | Высокомеченный тритием [3h]-(e)-n-[(4-гидрокси-3-метоксифенил)метил]-8-метил-6-ноненамид |
| JPWO2007013690A1 (ja) * | 2005-07-28 | 2009-02-12 | 味の素株式会社 | 顧客に適する局所塗布剤とサプリメントとを提供する方法 |
| US20090093446A1 (en) * | 2007-10-05 | 2009-04-09 | Winston Laboratories, Inc. | Method for alleviating keratoconjunctivitis sicca |
| US20110014269A1 (en) * | 2009-07-14 | 2011-01-20 | Winston Laboratories, Inc. | Civamide patch for localized post-incisional neuropathic pain |
| US20110200669A1 (en) * | 2010-02-15 | 2011-08-18 | Winston Laboratories, Inc. | Method and compositions of civamide to treat disease of the intestines |
| US11166925B2 (en) | 2018-08-23 | 2021-11-09 | Elorac, Inc. | Method for alleviating keratoconjunctivitis sicca |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4460602A (en) * | 1981-06-30 | 1984-07-17 | The Procter & Gamble Company | Urea derivatives |
| US4546112A (en) * | 1981-12-14 | 1985-10-08 | The Procter & Gamble Company | Method for preventing or reducing dipilatory irritation |
| US4536404A (en) * | 1983-06-16 | 1985-08-20 | Dermatological Enterprises, Ltd. | Method and composition for treating post-herpetic neuralgia |
| US4493848A (en) * | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
| US4681897A (en) * | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| US4599342A (en) * | 1984-01-16 | 1986-07-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| US4702916A (en) * | 1985-12-03 | 1987-10-27 | Warner-Lambert Company | Analgesic stick compositions |
-
1989
- 1989-12-19 US US07/452,476 patent/US5063060A/en not_active Expired - Lifetime
-
1990
- 1990-06-28 DE DE69027220T patent/DE69027220T2/de not_active Expired - Fee Related
- 1990-06-28 WO PCT/US1990/003674 patent/WO1991008738A1/en not_active Ceased
- 1990-06-28 JP JP2510990A patent/JPH0780761B2/ja not_active Expired - Fee Related
- 1990-06-28 CA CA002070685A patent/CA2070685C/en not_active Expired - Lifetime
- 1990-06-28 EP EP90911873A patent/EP0506658B1/de not_active Expired - Lifetime
- 1990-06-28 ES ES90911873T patent/ES2087160T3/es not_active Expired - Lifetime
- 1990-06-28 DK DK90911873.9T patent/DK0506658T3/da active
- 1990-06-28 KR KR1019920701410A patent/KR950015056B1/ko not_active Expired - Fee Related
- 1990-06-28 AT AT90911873T patent/ATE138567T1/de not_active IP Right Cessation
- 1990-06-28 RU SU905052768A patent/RU2095060C1/ru active
- 1990-06-28 AU AU60648/90A patent/AU645023B2/en not_active Ceased
- 1990-09-27 IL IL9582090A patent/IL95820A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0506658T3 (da) | 1996-06-24 |
| ES2087160T3 (es) | 1996-07-16 |
| US5063060A (en) | 1991-11-05 |
| ATE138567T1 (de) | 1996-06-15 |
| DE69027220D1 (de) | 1996-07-04 |
| JPH0780761B2 (ja) | 1995-08-30 |
| EP0506658A4 (en) | 1993-03-03 |
| KR920703041A (ko) | 1992-12-17 |
| WO1991008738A1 (en) | 1991-06-27 |
| JPH05504546A (ja) | 1993-07-15 |
| CA2070685C (en) | 1994-11-01 |
| EP0506658B1 (de) | 1996-05-29 |
| AU645023B2 (en) | 1994-01-06 |
| AU6064890A (en) | 1991-07-18 |
| RU2095060C1 (ru) | 1997-11-10 |
| DE69027220T2 (de) | 1997-01-02 |
| KR950015056B1 (ko) | 1995-12-21 |
| CA2070685A1 (en) | 1991-06-20 |
| EP0506658A1 (de) | 1992-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5063060A (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| KR20010078754A (ko) | 통증 경감 방법 및 통증 경감용 경피 조성물 | |
| CN101541182A (zh) | 用于治疗病毒疾病的提取物的应用 | |
| US11007241B2 (en) | Compositions for relieving pain with malkangni oil and cypriol oil as active ingredients and method of topical administration of the same | |
| JP2002527392A (ja) | 末梢的に作用する抗掻痒アヘン剤 | |
| EP3677265A1 (de) | Zusammensetzung zur vorbeugung oder behandlung von schlafstörungen | |
| US7772275B2 (en) | Compositions and method for treating affective, painful or allergic disorders | |
| US4312865A (en) | Medication having penetration through cutaneous surfaces into articular and muscular areas | |
| EP1318801B1 (de) | Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung | |
| JP2002322071A (ja) | 蜂針を用いない蜂毒療法 | |
| JPH0473413B2 (de) | ||
| CZ147894A3 (en) | Pain inhibiting pharmacological preparation and process for preparing thereof | |
| JPH10513454A (ja) | ルビジウムイオンを用いる治療法およびその製剤 | |
| KR102927058B1 (ko) | 진통 가려움 완화 약학 조성물 및 그 응용 방법 | |
| JP2001526217A (ja) | 血管性頭痛に対する局所麻酔薬の新規な使用 | |
| EP1148883B1 (de) | Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen | |
| EP1156830A2 (de) | Öl-in-wasser-emulsion zur verwendung als arzneimittel bzw. zur herstellung eines arzneimittels | |
| HU207446B (en) | Method for producing medicinal preparation of local use | |
| IT8247658A1 (it) | Medicamenti a base di derivati condensati dell'imidazolo per il trattamento di disturbi urinari | |
| EP1669064A1 (de) | Zusammensetzung und Methode einer topischen Therapie von Neurodermitis | |
| KR20000017706A (ko) | 국소마취제를함유한약용겔제조성물 | |
| JPS60208907A (ja) | 毛髪成長刺激剤 | |
| JPH08198775A (ja) | 薬浸投薬法及びその補助剤 | |
| EP1749528A1 (de) | Pharmazeutische Kombinationen, welche mu-opioid Agonisten und Inhibitoren der Stickstoffmonoxidherstellung enthalten | |
| CN106943392A (zh) | 一种用于治疗小儿疝气的药物组合物及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |